Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15212760

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

Author
ICHIKAWA, W1 ; UETAKE, H2 ; SHIROTA, Y2 ; YAMADA, H2 ; TAKAHASHI, T1 ; NIHEI, Z1 ; SUGIHARA, K2 ; SASAKI, Y3 ; HIRAYAMA, R1
[1] Second Department of Surgery, Saitama Medical School, 38, Moro-Hongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan
[2] Department of Digestive Surgery, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
[3] Department of Clinical Oncology, Saitama Medical School, 38, Moro-Hongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan
Source

British journal of cancer. 2003, Vol 89, Num 8, pp 1486-1492, 7 p ; ref : 41 ref

CODEN
BJCAAI
ISSN
0007-0920
Scientific domain
Medical oncology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
dihydropyrimidine dehydrogenase fluoropyrimidine-based chemotherapy metastatic colorectal cancer orotate phosphoribosyl transferase
Keyword (fr)
Anticancéreux Antimétabolite Association médicamenteuse Cancer colorectal Chimiothérapie Dihydropyrimidine dehydrogenase (NADP+) Expression génique Fluoropyrimidine dérivé Folinate de calcium Homme Orotate phosphoribosyltransferase Pronostic Pyrimidine dérivé Ratio Stade avancé Traitement Tégafur Uracile Appareil digestif pathologie Côlon pathologie Enzyme Glycosyltransferases Génétique Intestin pathologie Oxidoreductases Pentosyltransferases Rectum pathologie Transferases Tumeur maligne
Keyword (en)
Antineoplastic agent Antimetabolic Drug combination Colorectal cancer Chemotherapy Dihydropyrimidine dehydrogenase (NADP+) Gene expression Fluoropyrimidine derivatives Calcium folinate Human Orotate phosphoribosyltransferase Prognosis Pyrimidine derivatives Ratio Advanced stage Treatment Tegafur Uracil Digestive diseases Colonic disease Enzyme Glycosyltransferases Genetics Intestinal disease Oxidoreductases Pentosyltransferases Rectal disease Transferases Malignant tumor
Keyword (es)
Anticanceroso Antimetabólito Asociación medicamentosa Cancer de colon y recto Quimioterapia Dihydropyrimidine dehydrogenase (NADP+) Expresión genética Fluoropirimidina derivado Folinato cálcico Hombre Orotate phosphoribosyltransferase Pronóstico Pirimidina derivado Ratio Estadio avanzado Tratamiento Tegafur Uracilo Aparato digestivo patología Colón patología Enzima Glycosyltransferases Genética Intestino patología Oxidoreductases Pentosyltransferases Recto patología Transferases Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
15212760

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web